Northern Capital Management (Washington)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255K | Hold |
1,372
| – | – | 0.15% | 34 |
|
|
2025
Q1 | $287K | Hold |
1,372
| – | – | 0.19% | 33 |
|
|
2024
Q4 | $244K | Sell |
1,372
-114
| -8% | -$20.3K | 0.15% | 34 |
|
|
2024
Q3 | $294K | Sell |
1,486
-43
| -3% | -$8.49K | 0.19% | 30 |
|
|
2024
Q2 | $262K | Sell |
1,529
-182
| -11% | -$31.2K | 0.18% | 30 |
|
|
2024
Q1 | $312K | Buy |
1,711
+107
| +7% | +$19.5K | 0.22% | 27 |
|
|
2023
Q4 | $249K | Buy |
1,604
+3
| +0.2% | +$465 | 0.22% | 25 |
|
|
2023
Q3 | $239K | Sell |
1,601
-17
| -1% | -$2.53K | 0.22% | 32 |
|
|
2023
Q2 | $218K | Buy |
1,618
+3
| +0.2% | +$404 | 0.17% | 39 |
|
|
2023
Q1 | $257K | Buy |
1,615
+3
| +0.2% | +$478 | 0.22% | 34 |
|
|
2022
Q4 | $261K | Sell |
1,612
-47
| -3% | -$7.6K | 0.25% | 35 |
|
|
2022
Q3 | $223K | Buy |
1,659
+3
| +0.2% | +$403 | 0.23% | 32 |
|
|
2022
Q2 | $254K | Sell |
1,656
-216
| -12% | -$33.1K | 0.25% | 30 |
|
|
2022
Q1 | $303K | Buy |
1,872
+260
| +16% | +$42.1K | 0.25% | 31 |
|
|
2021
Q4 | $218K | Buy |
+1,612
| New | +$218K | 0.17% | 40 |
|